Literature DB >> 9720959

Protective immunity in coccidioidomycosis.

R A Cox1, D M Magee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9720959     DOI: 10.1016/s0923-2494(98)80765-7

Source DB:  PubMed          Journal:  Res Immunol        ISSN: 0923-2494


× No keyword cloud information.
  16 in total

1.  Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis.

Authors:  C Jiang; D M Magee; R A Cox
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.

Authors:  Eric J Tarcha; Venkatesha Basrur; Chiung-Yu Hung; Malcolm J Gardner; Garry T Cole
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.

Authors:  C Jiang; D M Magee; T N Quitugua; R A Cox
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

4.  Construction of a single-chain interleukin-12-expressing retroviral vector and its application in cytokine gene therapy against experimental coccidioidomycosis.

Authors:  C Jiang; D M Magee; R A Cox
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

5.  Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and Dectin-1.

Authors:  Suganya Viriyakosol; Joshua Fierer; Gordon D Brown; Theo N Kirkland
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

6.  Protection of mice against Coccidioides immitis intranasal infection by vaccination with recombinant antigen 2/PRA.

Authors:  Lisa Shubitz; Tao Peng; Robert Perrill; Julie Simons; Kris Orsborn; John N Galgiani
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

7.  High levels of interleukin-10 impair resistance to pulmonary coccidioidomycosis in mice in part through control of nitric oxide synthase 2 expression.

Authors:  Maria del Pilar Jimenez; Lorraine Walls; Joshua Fierer
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

8.  Coccidioidomycosis Pulmonary Infection.

Authors:  Jiejian Lin; Richard J. Hamill
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

Review 9.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

10.  A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.

Authors:  Jianmin Xue; Xia Chen; Dale Selby; Chiung-Yu Hung; Jieh-Juen Yu; Garry T Cole
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.